Advertisement

Inpharma Weekly

, Volume 933, Issue 1, pp 7–8 | Cite as

Risperidone

does it give ‘enough bang for the buck’?
  • Greg L Plosker
Newsletter Article

Abstract

Risperidone is expensive but, apparently, not too expensive. Recent Canadian guidelines suggest a cut-off point for how much spending can be justified per quality-adjusted life-year (QALY) gained when comparing old treatments with new. And a recent cost-utility study conducted by Janssen researchers has determined that risperidone comes close enough to this cut-off point to be recommended as treatment for schizophrenia. The results of this study were discussed at the 20th Annual Canadian Society of Hospital Pharmacists (Western Branches) [Banff, Alberta, Canada; March 1994].

Keywords

Schizophrenia Haloperidol Clozapine Risperidone Antipsychotic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1994

Authors and Affiliations

  • Greg L Plosker

There are no affiliations available

Personalised recommendations